Found 7 matching trials
Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis PHASE3 The purpose of this study is to investigate the safety and efficacy of a lo...
Show More Location
North Central Neurology Associates, PC
Learn More & Join Trial
Efficacy of Dalfampridine on Upper Extremity Function in Patients With MS PHASE4 This study evaluates the effects of sustained-release oral dalfampridine in...
Show More Location
Multiple Sclerosis Center
Learn More & Join Trial
A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis PHASE3 This is a multicenter study conducted in 3 parts. Part A is a double-blind ...
Show More Learn More & Join Trial
A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene PHASE3 Spinocerebellar ataxias 27B (SCA27B) is caused by an expansion of ≥ 250 GAA...
Show More Location
Neurology Department, CHU d'Angers
Learn More & Join Trial
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. PHASE2 The objectives of this study in Multiple Sclerosis (MS) participants treate...
Show More Learn More & Join Trial
A Pharmacokinetics (PK) and Safety Study of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy Volunteers PHASE1 The primary objective of the study is to determine the Pharmacokinetic (PK)...
Show More Learn More & Join Trial
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine. PHASE3 This is an extension study to evaluate the long-term safety, tolerability, ...
Show More Learn More & Join Trial